Evoke Pharma Inc Quick Ratio in % from Q2 2021 to Q3 2025

Taxonomy & unit
ratio: %
Description
The acid-test ratio, also called the quick ratio, is a metric used to see if a company is positioned to sell assets within 90 days to meet immediate expenses.
Summary
Evoke Pharma Inc quarterly Quick Ratio history and growth rate from Q2 2021 to Q3 2025.
  • Evoke Pharma Inc Quick Ratio for the quarter ending September 30, 2025 was 4.96 %, a 10.9% decline year-over-year.
Quick Ratio, Quarterly (%)
Quick Ratio, YoY Quarterly Growth (%)

Evoke Pharma Inc Quarterly Quick Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 4.96 -0.61 -10.9% Sep 30, 2025
Q2 2025 5 -0.76 -13.2% Jun 30, 2025
Q1 2025 5.03 -0.81 -13.9% Mar 31, 2025
Q4 2024 5.37 -1.18 -18% Dec 31, 2024
Q3 2024 5.57 -2.59 -31.7% Sep 30, 2024
Q2 2024 5.76 -4.41 -43.4% Jun 30, 2024
Q1 2024 5.84 -11.6 -66.4% Mar 31, 2024
Q4 2023 6.55 -10.4 -61.3% Dec 31, 2023
Q3 2023 8.16 -7.74 -48.7% Sep 30, 2023
Q2 2023 10.2 -7.23 -41.6% Jun 30, 2023
Q1 2023 17.4 +8.52 +95.8% Mar 31, 2023
Q4 2022 16.9 +11.2 +194% Dec 31, 2022
Q3 2022 15.9 +11.6 +265% Sep 30, 2022
Q2 2022 17.4 +14.4 +485% Jun 30, 2022
Q1 2022 8.89 Mar 31, 2022
Q4 2021 5.77 Dec 31, 2021
Q3 2021 4.35 Sep 30, 2021
Q2 2021 2.98 Jun 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.